Description
Remoqueen (Mirtazapine) 15 mg
Remoqueen 15 mg is a brand of mirtazapine, an antidepressant medicine used for the treatment of major depressive disorder. The product description supplied identifies the strength as 15 mg; the active ingredient is mirtazapine.
Active Ingredient and Medicine Class
Active ingredient: mirtazapine.
Medicine class: tetracyclic antidepressant, also described as a noradrenergic and specific serotonergic antidepressant.
Established Medical Uses
Mirtazapine is established for the treatment of major depressive disorder. Regulatory prescribing information describes its approved use in depression, and clinical reviews support its role as an antidepressant option in adults.
How It Works
Mirtazapine works by changing the activity of brain chemicals involved in mood. It enhances noradrenergic and serotonergic neurotransmission through receptor blockade rather than by inhibiting serotonin reuptake. It has strong effects on histamine H1 receptors and also blocks certain serotonin receptors, which helps explain both its antidepressant action and some of its sedating effects.
Important Safety Information
Mirtazapine must not be used together with monoamine oxidase inhibitors, including linezolid or intravenous methylene blue, because of the risk of serotonin syndrome. Prescribing information also warns about serotonin syndrome when combined with other serotonergic medicines. Caution is advised in people with a history of bipolar disorder, seizure disorders, severe liver impairment, or factors that may increase the risk of QT prolongation. As with other antidepressants, monitoring is important for worsening depression or emergent suicidal thoughts, especially early in treatment. Clinically important interactions can occur with other serotonergic agents and with medicines that affect cardiac rhythm or central nervous system sedation.
Possible Side Effects
Common adverse effects include drowsiness, dry mouth, increased appetite, and weight gain. Other reported effects include dizziness, constipation, and fatigue. Serious reactions can include serotonin syndrome, severe allergic reactions, low white blood cell counts, manic symptoms, and heart rhythm problems such as QT prolongation and torsades de pointes.
Scientific Evidence
PubMed-indexed reviews and meta-analyses show that mirtazapine is an effective antidepressant for major depression and is often associated with a distinct tolerability profile compared with older antidepressants. Evidence also suggests fewer anticholinergic and some cardiovascular adverse effects than amitriptyline, while sedation and weight gain remain important limitations. More recent review literature continues to support its established antidepressant efficacy.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
